AMN082

Chemical structure of AMN082

AMN082 is a chemical compound that acts as a selective agonist for the metabotropic glutamate receptor subtype 7 (mGluR7). It is primarily used in scientific research to study the role of mGluR7 in the central nervous system and its potential implications in various neurological disorders.

Mechanism of Action

AMN082 functions by binding to and activating the mGluR7 receptor, which is a member of the group III metabotropic glutamate receptors. These receptors are G-protein coupled receptors that modulate neurotransmission in the brain. Activation of mGluR7 by AMN082 leads to the inhibition of adenylyl cyclase, resulting in decreased levels of cyclic adenosine monophosphate (cAMP) within the cell. This modulation of intracellular signaling pathways can influence synaptic plasticity and neuronal excitability.

Research Applications

AMN082 is utilized in research to explore the physiological and pathological roles of mGluR7. Studies have investigated its effects on anxiety, depression, and schizophrenia, as well as its potential neuroprotective properties. By understanding how AMN082 interacts with mGluR7, researchers aim to develop new therapeutic strategies for treating these conditions.

Pharmacological Effects

The administration of AMN082 in animal models has shown to produce anxiolytic and antidepressant-like effects. It has also been observed to modulate dopaminergic and serotonergic neurotransmission, which are critical pathways involved in mood regulation and cognitive function.

Safety and Toxicology

While AMN082 is a valuable tool in research, its safety profile in humans is not well-established. Most studies have been conducted in vitro or in animal models, and further research is needed to determine its potential therapeutic applications and safety in humans.

Related Pages

• Metabotropic glutamate receptor
• Neurotransmitter
• Central nervous system
• G-protein coupled receptor